Amneal Pharmaceuticals, Inc. (AMRX)

Healthcare · Drug Manufacturers Specialty Generic · NASDAQ

Amneal Pharmaceuticals, Inc. (AMRX) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $5.79B, a trailing price-to-earnings ratio of 19.1 and a free-cash-flow yield of 3.8%. Over the most recent reported fiscal year, revenue grew 8.1% and free cash flow per share fell 2.5%.

Market cap	$5.79B
Trailing P/E	19.1
FCF yield	3.8%
Revenue growth (YoY)	+8.1%
EPS growth (YoY)	+44.8%
FCF/share growth (YoY)	-2.5%
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live AMRX data on Nama Insights →

Recent Congressional trades

Amneal Pharmaceuticals, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Gilbert Cisneros	House	Sell	$1,001 - $15,000	Jun 7, 2019